Galderma Group AG's gross profit for the
six
months ended in Dec. 2024 was CHF1,369 Mil. Galderma Group AG's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was CHF2,754 Mil.
Galderma Group AG had a gross margin of 69.06% for the quarter that ended in Dec. 2024 => Durable competitive advantage
During the past 2 years, the highestGross Margin % of Galderma Group AG was 70.08%. The lowest was 69.48%. And the median was 69.78%.
Galderma Group AG Gross Profit Historical Data
The historical data trend for Galderma Group AG's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Galderma Group AG Gross Profit Chart
Galderma Group AG Annual Data
Trend
Dec23
Dec24
Gross Profit
2,494.95
2,750.59
Galderma Group AG Semi-Annual Data
Jun23
Dec23
Jun24
Dec24
Gross Profit
1,288.47
1,257.42
1,384.50
1,369.50
Competitive Comparison of Galderma Group AG's Gross Profit
For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galderma Group AG's Gross Profit Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Gross Profit distribution charts can be found below:
* The bar in red indicates where Galderma Group AG's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF2,754 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Galderma Group AG (CHIX:GALDz) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Galderma Group AG had a gross margin of 69.06% for the quarter that ended in Dec. 2024 => Durable competitive advantage
Galderma Group AG Gross Profit Related Terms
Thank you for viewing the detailed overview of Galderma Group AG's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHIX:GALDZ has been successfully added to your